EVELINA GONZALEZ: Open Payments
NPI 1790478634 · SAN FRANCISCO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$291 in 16 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $291
Food & beverage: $291
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $99 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $71 |
| AstraZeneca Pharmaceuticals LP | 3 | $50 |
| Lilly USA, LLC | 2 | $37 |
| Merck Sharp & Dohme LLC | 1 | $17 |
| Abbott Laboratories | 1 | $17 |
Products named: CAPLYTA, AIRSUPRA, QULIPTA, MOUNJARO, UBRELVY, ROTATEQ, FREESTYLE LIBRE 3, VRAYLAR.
Industry payments across CA — which companies pay providers there.
